Andrew Spaventa

Andrew Spaventa

Chief Executive Officer chez SINGULAR GENOMICS SYSTEMS, INC.

Fortune : 2 M $ au 31/03/2024

39 ans
Consumer Services
Finance
Health Services

Profil

Andrew Spaventa is the founder of Truvian Sciences, Inc. (founded in 2015), ecoATM LLC (founded in 2008), Singular Genomics Systems, Inc. (founded in 2016), and Aspen Neuroscience, Inc. (founded in 2018).
He is currently the Chairman, President & Chief Executive Officer at Singular Genomics Systems, Inc. and a Director at Aspen Neuroscience, Inc. He is also currently a Director at San Diego Venture Group since 2018 and the Managing Partner at Axon Ventures since 2014.
Mr. Spaventa previously worked as the Director-Market Development & Compliance at ecoATM LLC from 2008 to 2013.
He also held positions as a Principal at GeckoGroup AG and a Consultant at Tyche Global Strategy.
Mr. Spaventa completed his undergraduate and graduate degrees at the University of California San Diego and holds an MBA from the Rady School of Management at UC San Diego.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/03/2024 4 100 138 ( 5,55% ) 2 M $ 31/03/2024

Postes actifs de Andrew Spaventa

SociétésPosteDébut
SINGULAR GENOMICS SYSTEMS, INC. Chief Executive Officer 01/06/2016
Director/Board Member 01/01/2018
Founder 01/04/2018
Axon Ventures Corporate Officer/Principal 01/03/2014
Tous les postes actifs de Andrew Spaventa

Anciens postes connus de Andrew Spaventa

SociétésPosteFin
Founder 01/01/2013
Founder -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Andrew Spaventa

Formation de Andrew Spaventa

University of California San Diego Graduate Degree
Rady School of Management at UC San Diego Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Andrew Spaventa

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
SINGULAR GENOMICS SYSTEMS, INC.

Health Technology

Entreprise privées7

Finance

Utilities

Technology Services

Finance

Health Services

Health Services

Axon Ventures

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Andrew Spaventa